USE OF RECOMBINANT LINGZHI MUSHROOM IMMUNOMODULATORY PROTEIN IN PREPARATION OF DRUGS FOR TREATING FOCAL CEREBRAL ISCHEMIA

摘要

An application of a recombinant immunoregulatory protein of ganoderma lucidum (rLZ-8) expressed by Pichia pastoris in a preparation of a drug for treating focal cerebral ischemia is provided. The rLZ-8 is able to treat a neurological function injury, decrease a neurological severity score caused by a cerebral injury and decrease an ED-1 positive cell number, so as to decrease an inflammatory response and inhibit apoptosis.